Heart disease remains one of the leading health concerns in the United States, pushing millions of people to look for ways to strengthen their cardiovascular health. However, nutrition experts warn ...

The United States prides itself on freedom, but you might be surprised to learn that many everyday items and practices perfectly legal elsewhere are strictly ...

Drugs like Wegovy and Zepbound have been hailed as miracle treatments. But one in 10 people are what scientists call ...

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

Novo's drug, CagriSema, didn't achieve its key goal of demonstrating non-inferiority on weight loss when compared to Eli Lilly's rival drug tirzepatide. The stock plummeted on Monday, hitting its ...

Novo Nordisk has multiple weight-loss drugs in various stages of development and approval, according to its R&D pipeline. These include, among others, monlunabant (phase 2); oral and subcutaneous ...

Feb 23 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it received the U.S. Food and Drug Administration's approval to launch a four-dose KwikPen for its weight-loss drug Zepbound, ...

The FDA has approved a new four-dose, single-patient-use KwikPen for Zepbound (tirzepatide), giving patients a full month of treatment in one device. Lilly says the new pen expands patient choice, ...

Popular weight-loss medications may also affect aspects of sexual health, recent research has shown. In obese and overweight men, GLP-1 (glucagon-like peptide-1) drugs increased total testosterone, ...

Novo Nordisk received final approval for a higher dose of its Wegovy weight-loss shot from the European Commission. Approval of the higher 7.2 milligram dose of Wegovy means that doctors in the EU can ...